Taiwan Biomaterial Co., Ltd.(TW:6649)
NT$35.65-0.25 (-0.70%)
TW:6649
Taiwan Biomaterial Co., Ltd. financials statements
NT$35.65
At close:-0.25 (-0.70%)
Taiwan Biomaterial Co., Ltd. (6649) Ratios
Taiwan Biomaterial Co., Ltd. Ratios
TW:6649's free cash flow for Q2 2026 was NT$-55.89M. For the 2026 fiscal year, TW:6649's free cash flow was decreased by NT$-4.11M and operating cash flow was NT$-51.78M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 8.53 | 14.39 | 11.30 | 13.74 | 2.77 |
| Quick Ratio | 7.45 | 12.82 | 9.83 | 13.09 | 2.62 |
| Cash Ratio | 4.70 | 7.96 | 5.22 | 6.72 | 1.44 |
| Solvency Ratio | 0.72 | 0.20 | 0.09 | 0.57 | -0.28 |
| Operating Cash Flow Ratio | 0.89 | 0.71 | -0.31 | 1.29 | -0.50 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | -5.60 |
| Net Current Asset Value | NT$ 364.02M | NT$ 292.91M | NT$ 283.15M | NT$ 285.60M | NT$ 45.25M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.08 | 0.08 | 0.09 | 0.14 |
| Debt-to-Equity Ratio | 0.08 | 0.09 | 0.10 | 0.11 | 0.19 |
| Debt-to-Capital Ratio | 0.07 | 0.08 | 0.09 | 0.10 | 0.16 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.15 | 1.13 | 1.14 | 1.14 | 1.31 |
| Debt Service Coverage Ratio | 102.97 | 20.87 | 9.87 | 53.06 | -5.24 |
| Interest Coverage Ratio | 82.09 | -13.99 | -16.31 | 26.17 | -55.07 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Interest Debt Per Share | 1.27 | 1.38 | 1.46 | 1.70 | 2.44 |
| Net Debt to EBITDA | -2.70 | -9.27 | -11.44 | -2.22 | 0.34 |
| Profitability Margins | |||||
| Gross Profit Margin | 55.85% | 59.34% | 64.69% | 59.77% | 50.60% |
| EBIT Margin | 27.07% | -1.75% | -11.20% | 27.28% | -111.37% |
| EBITDA Margin | 34.62% | 16.56% | 13.32% | 40.56% | -84.82% |
| Operating Profit Margin | 27.60% | -11.63% | -19.53% | 20.00% | -136.10% |
| Pretax Profit Margin | 26.74% | -2.58% | -12.40% | 26.51% | -113.84% |
| Net Profit Margin | 26.74% | -1.79% | -13.91% | 26.51% | -113.84% |
| Continuous Operations Profit Margin | 26.74% | -1.79% | -13.91% | 26.51% | -113.84% |
| Net Income Per EBT | 100.00% | 69.47% | 112.17% | 100.00% | 100.00% |
| EBT Per EBIT | 96.87% | 22.19% | 63.49% | 132.56% | 83.65% |
| Return on Assets (ROA) | 7.46% | -0.25% | -1.41% | 4.59% | -8.57% |
| Return on Equity (ROE) | 8.60% | -0.28% | -1.61% | 5.22% | -11.22% |
| Return on Capital Employed (ROCE) | 8.28% | -1.66% | -2.08% | 3.60% | -11.57% |
| Return on Invested Capital (ROIC) | 8.23% | -1.14% | -2.07% | 3.56% | -11.28% |
| Return on Tangible Assets | 7.48% | -0.25% | -1.42% | 4.61% | -8.60% |
| Earnings Yield | 3.02% | -0.12% | -0.77% | 2.38% | -5.80% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.96 | 7.84 | 4.89 | 0.00 | 0.00 |
| Payables Turnover | 4.81 | 8.35 | 3.12 | 13.76 | 22.02 |
| Inventory Turnover | 1.64 | 0.97 | 0.53 | 2.88 | 2.06 |
| Fixed Asset Turnover | 0.81 | 0.30 | 0.22 | 0.36 | 0.11 |
| Asset Turnover | 0.28 | 0.14 | 0.10 | 0.17 | 0.08 |
| Working Capital Turnover Ratio | 0.58 | 0.28 | 0.21 | 0.55 | 0.26 |
| Cash Conversion Cycle | 207.86 | 380.14 | 644.95 | 100.30 | 160.32 |
| Days of Sales Outstanding | 61.21 | 46.54 | 74.60 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 222.61 | 377.33 | 687.43 | 126.83 | 176.90 |
| Days of Payables Outstanding | 75.96 | 43.73 | 117.08 | 26.53 | 16.58 |
| Operating Cycle | 283.82 | 423.87 | 762.03 | 126.83 | 176.90 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.16 | 0.44 | -0.24 | 0.86 | -0.97 |
| Free Cash Flow Per Share | 1.13 | 0.33 | -0.32 | -0.06 | -1.87 |
| Dividend Paid and CapEx Coverage Ratio | 33.78 | 3.97 | -0.88 | 0.93 | -1.08 |
| Capital Expenditure Coverage Ratio | 33.78 | 3.97 | -3.16 | 0.93 | -1.08 |
| Operating Cash Flow Coverage Ratio | 0.93 | 0.32 | -0.17 | 0.51 | -0.40 |
| Operating Cash Flow to Sales Ratio | 0.22 | 0.19 | -0.14 | 0.28 | -0.77 |
| Free Cash Flow Yield | 2.42% | 0.96% | -1.02% | -0.17% | -7.54% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 33.21 | -830.10 | -129.17 | 41.81 | -17.22 |
| Price-to-Sales (P/S) Ratio | 8.86 | 14.87 | 17.96 | 11.14 | 19.64 |
| Price-to-Book (P/B) Ratio | 2.85 | 2.29 | 2.08 | 2.19 | 1.94 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 41.27 | 104.22 | -97.83 | -578.32 | -13.26 |
| Price-to-Operating Cash Flow Ratio | 40.04 | 77.95 | -128.75 | 40.49 | -25.57 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 10.02 | 1.00 | -0.27 | 1.55 |
| Enterprise Value Multiple | 22.90 | 80.53 | 123.39 | 25.25 | -22.81 |
| Enterprise Value | 1.75B | 1.29B | 1.20B | 1.30B | 806.39M |
| EV to EBITDA | 22.90 | 80.53 | 123.39 | 25.25 | -22.81 |
| EV to Sales | 7.93 | 13.34 | 16.44 | 10.24 | 19.35 |
| EV to Free Cash Flow | 36.92 | 93.45 | -89.53 | -531.57 | -13.07 |
| EV to Operating Cash Flow | 35.82 | 69.90 | -117.83 | 37.21 | -25.19 |
| Tangible Book Value Per Share | 16.27 | 14.88 | 14.84 | 15.82 | 12.81 |
| Shareholders’ Equity Per Share | 16.31 | 14.91 | 14.88 | 15.82 | 12.81 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.31 | -0.12 | 0.00 | 0.00 |
| Revenue Per Share | 5.25 | 2.30 | 1.73 | 3.12 | 1.26 |
| Net Income Per Share | 1.40 | -0.04 | -0.24 | 0.83 | -1.44 |
| Tax Burden | 1.00 | 0.69 | 1.12 | 1.00 | 1.00 |
| Interest Burden | 0.99 | 1.48 | 1.11 | 0.97 | 1.02 |
| Research & Development to Revenue | 0.11 | 0.32 | 0.31 | 0.25 | 1.55 |
| SG&A to Revenue | 0.23 | 0.39 | 0.53 | 0.26 | 0.56 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Income Quality | 0.83 | -7.39 | 1.00 | 1.04 | 0.67 |
Currency in TWD
